A RANDOMIZED TRIPLE BLIND, PLACEBO- CONTROLLED TRIAL TO DETERMINE EFFECTIVENESS OF RIFAXIMIN IN PREVENTING HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CHRONIC LIVER DISEASE
Journal: Indo American Journal of Pharmaceutical Sciences (IAJPS) (Vol.05, No. 04)Publication Date: 2018-04-09
Authors : Abdur Rehman Aqeel Binyamin Butt Hira Naveed Ali Arshad;
Page : 2728-2732
Keywords : Hepatic encephalopathy; rifaximin; cirrhosis; placebo; chronic liver disease; recurrence.;
Abstract
Objective: To study the effectiveness of using rifaximin for prevention of recurrent hepatic encephalopathy (HE) attacks in patients with chronic liver disease (CLD). Methods: This study was conducted at the hepatology department of Mayo Hospital, Lahore, during October 2014 to April 2015 by following randomized, triple blind, placebo-controlled trial. Total 126 patients of CLD, who during remission from hepatic encephalopathy were prescribed rifaximin 550mg, two times a day for six months or placebo was advised twice daily for six months. Patients were advised to either take drug from 6 months or till onset of hepatic encephalopathy episode. These prescriptions were advised after randomly dividing patients into two groups consisting of 63 each. Results: The participants had mean age group 40.2 ± 2.3 years and 42.8 ± 4.5 years in test group and control group, respectively. Hepatitis C was found to be more common cause of cirrhosis as compared to hepatitis B. Forty out of 63 patients remained free from hepatic encephalopathy in test group while 35 patients did not suffer HE in control group during study period. Those who suffered HE had MELD scoring from 21 to 25 in both groups. There were similar adverse reactions and deaths in both groups. Conclusion: Rifaximin has no effective role in preventing hepatic encephalopathy as compared to placebo. Key Words: Hepatic encephalopathy, rifaximin, cirrhosis, placebo, chronic liver disease, recurrence.
Other Latest Articles
- INCIDENCE OF NOSOCOMIAL PATHOGENS ON THE MOBILE PHONES
- PREPARATION AND EVALUATION OF CHITOSAN - GLICLAZIDE MICROPARTICULATE DRUG DELIVERY SYSTEMS BY AN EMULSIFICATION- DESOLVATION- CROSSLINKING TECHNIQUE
- SCREENING OF POTENTIAL ANTIBIOTIC PRODUCING ACTINOMYCETES FROM THE SOIL OF GANGA RIVER BED OF HARIDWAR
- SELF EFFICACY COMMUNITY HEALTH WORKERS WITH CULTURAL DIVERSITY IN THE CONTEXT OF THE PUBLIC BEACHES, VALLEYS AND MOUNTAINS IN THE PROVINCE OF PAPUA
- EVALUATION OF FATTY ACID, MINERAL AND VITAMIN COMPOSITIONS OF LAURENCIA PAPILLOSA FROM THE SOUTH EAST COAST OF INDIA
Last modified: 2018-05-02 03:09:45